Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Beatrice Campi
Phase II Study of Dehydroepiandrosterone in Androgen Receptor‐Positive Metastatic Breast Cancer
Oncologist
Cancer Research
Medicine
Oncology
Related publications
Androgen Receptor-Positive, Triple-Negative Breast Cancer
Cancer
Cancer Research
Oncology
Phase 1b Study of Orteronel in Postmenopausal Women With Hormone-Receptor Positive (HR+) Metastatic Breast Cancer
Investigational New Drugs
Oncology
Pharmacology
Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer
Scientific Reports
Multidisciplinary
A Prospective Phase II Study of Combined Androgen Blockade in Patients With Androgen Receptor-Positive Metastatic or Locally Advanced Unresectable Salivary Gland Carcinoma
Annals of Oncology
Medicine
Oncology
Hematology
Phase II Study of Pembrolizumab and Capecitabine for Triple Negative and Hormone Receptor-Positive, HER2−negative Endocrine-Refractory Metastatic Breast Cancer
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Prohibitin Promotes Androgen Receptor Activation in ER-positive Breast Cancer
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
Phase II Trial of Fulvestrant With Metronomic Capecitabine for Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology
The Androgen Receptor in Breast Cancer
Frontiers in Endocrinology
Endocrinology
Metabolism
Diabetes
Androgen Receptor in Male Breast Cancer
Polish Journal of Pathology
Medicine
Forensic Medicine
Pathology